FindTrial
Sign In

Clinical Study To See Effect Of Kwath In Managing Aamavat in reference To Arthritis

A Randomized Controlled Clinical Study To Evaluate The Efficacy Of Vaishwanar Kwath In The Management Of Aamavata W.S.R.To Rheumatoid Arthritis - Nil

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/03/082233
Enrollment
60
Registered
2025-03-12
Start date
Unknown
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M259- Joint disorder, unspecified

Interventions

None listed

Sponsors

Dr VJD Gramin Ayurveda Mahavidyalaya
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1)Patients willing for clinical trial. 2)Patient having the sign and symptom of Aamvata. 3)The patients of age group 20 to 60 years will be selected. 4)The patients will be selected irrespective of sex & religion. 5)RA test positive patients.

Exclusion criteria

Exclusion criteria: )Patients not willing for clinical trial. 2)Age less than 20 years and more than 60 years. 3)Chronicity more than 5 yr. 4)Any severe deformity. 5)Pregnant woman,lactating mothers. 6) Any other major illness like HIV, AIDS, TB, HTN, DM and malignancy.

Design outcomes

Primary

MeasureTime frame
Symptoms like1. Sandhishool - Vruschik danshavat vedana 2.Sanchari vedana 3.Sandhishotha 4.Sandhistambha 5.Sandhi sparshasahatva 6.Sandhi aushnya will be decreased and control over Amavata with reference to Rhematoid arthritisTimepoint: 15 days, 30 days and 45 days after starting treatment—

Secondary

MeasureTime frame
Decrease in symptoms of AmvataTimepoint: 18 months—

Countries

India

Contacts

Public ContactDr Jayashree Katole

Dr. VJD Gramin Ayurveda MahavidyalayaPatur, Akola

drjrkatole@gmail.com9423847608

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026